<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Press Releases</title>
	<atom:link href="https://www.worldpharmatoday.com/press-releases/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.worldpharmatoday.com</link>
	<description>Magazine for the C-level Pharma Executives</description>
	<lastBuildDate>Wed, 02 Sep 2026 13:35:24 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1</generator>

<image>
	<url>https://www.worldpharmatoday.com/wp-content/uploads/2025/12/cropped-World-Pharma-Today-fevicon-32x32.jpg</url>
	<title>Press Releases</title>
	<link>https://www.worldpharmatoday.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Syntegon opens new OSD Customer Center in Fellbach</title>
		<link>https://www.worldpharmatoday.com/press-releases/syntegon-opens-new-osd-customer-center-in-fellbach/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Wed, 02 Sep 2026 13:34:12 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/syntegon-opens-new-osd-customer-center-in-fellbach/</guid>

					<description><![CDATA[<p>State-of-the-art customer center for the pharmaceutical and nutraceutical industries Customer focus, innovation, and growth under one roof Close collaboration between customer center and production for even faster time-to-market of new drugs and nutraceuticals Stuttgart (Germany), September 1, 2026. Syntegon, a strategic lifecycle partner to the pharmaceutical, biotech, and food industries, has opened its new OSD [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/syntegon-opens-new-osd-customer-center-in-fellbach/">Syntegon opens new OSD Customer Center in Fellbach</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Galen and POA Pharma unveil Galsana, a new global brand for rare metabolic diseases</title>
		<link>https://www.worldpharmatoday.com/press-releases/galen-and-poa-pharma-unveil-galsana-a-new-global-brand-for-rare-metabolic-diseases/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Fri, 28 Aug 2026 08:15:42 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/galen-and-poa-pharma-unveil-galsana-a-new-global-brand-for-rare-metabolic-diseases/</guid>

					<description><![CDATA[<p>New global brand creates a stronger platform for innovation, partnerships and growth At the SSIEM Annual Symposium in Helsinki, Galen Ltd and POA Pharma announced the launch of Galsana, a new global brand for their metabolic product portfolio, bringing together established products, expertise and support services under a single identity. Galsana represents the next stage [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/galen-and-poa-pharma-unveil-galsana-a-new-global-brand-for-rare-metabolic-diseases/">Galen and POA Pharma unveil Galsana, a new global brand for rare metabolic diseases</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Centrix Pharma Solutions and University of Sussex partner to advance data-driven pharmaceutical development </title>
		<link>https://www.worldpharmatoday.com/press-releases/centrix-pharma-solutions-and-university-of-sussex-partner-to-advance-data-driven-pharmaceutical-development/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Fri, 28 Aug 2026 08:03:12 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/centrix-pharma-solutions-and-university-of-sussex-partner-to-advance-data-driven-pharmaceutical-development/</guid>

					<description><![CDATA[<p>Centrix Pharma Solutions, a UK-based Contract Development Manufacturing Organisation (CDMO) with strong scientific and manufacturing expertise, has partnered with the University of Sussex on a new Knowledge Transfer Partnership (KTP) that will use advanced data analytics and predictive modelling to transform pharmaceutical product development by enabling smarter, data-driven decision-making. Supported by Innovate UK, the £375,000 [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/centrix-pharma-solutions-and-university-of-sussex-partner-to-advance-data-driven-pharmaceutical-development/">Centrix Pharma Solutions and University of Sussex partner to advance data-driven pharmaceutical development </a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Syntegon Expands Sepion Series With New Pilot-Scale Tablet Coater</title>
		<link>https://www.worldpharmatoday.com/press-releases/syntegon-expands-sepion-series-with-new-pilot-scale-tablet-coater/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Wed, 19 Aug 2026 10:23:45 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/syntegon-expands-sepion-series-with-new-pilot-scale-tablet-coater/</guid>

					<description><![CDATA[<p>Syntegon completes its coater portfolio with new Sepion 75 Flexible batch processing, scalable process conditions, and containment-oriented design combined with closed material handling Consistent process principles enable direct parameter transfer from pilot to commercial scale as well as reproducible coating results Syntegon, a strategic lifecycle partner to the pharmaceutical and biotech industry has expanded its [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/syntegon-expands-sepion-series-with-new-pilot-scale-tablet-coater/">Syntegon Expands Sepion Series With New Pilot-Scale Tablet Coater</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>DeepCyte Launches World&#8217;s First Single-Cell Mechanistic Toxicity Atlas as Enterprise Pharma Pilots Advance</title>
		<link>https://www.worldpharmatoday.com/press-releases/deepcyte-launches-worlds-first-single-cell-mechanistic-toxicity-atlas-as-enterprise-pharma-pilots-advance/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Wed, 19 Aug 2026 09:18:39 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biopharmaceutical Development]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[Findings]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/deepcyte-launches-worlds-first-single-cell-mechanistic-toxicity-atlas-as-enterprise-pharma-pilots-advance/</guid>

					<description><![CDATA[<p>Proprietary training dataset spanning 300,000 cells and ~100 compounds positions DeepCyte to transform preclinical toxicology with mechanism-based prediction DeepCyte Inc., a techbio company building AI toxicology tools for drug development, today announced the launch of DeeTox Atlas™, the world&#8217;s first single-cell metabolomic reference atlas of drug toxicity mechanisms. Enterprise pilot programs with global pharmaceutical companies [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/deepcyte-launches-worlds-first-single-cell-mechanistic-toxicity-atlas-as-enterprise-pharma-pilots-advance/">DeepCyte Launches World’s First Single-Cell Mechanistic Toxicity Atlas as Enterprise Pharma Pilots Advance</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Telangana Aims to Emerge as India’s Life Sciences Innovation Capital with $25B Investment Target by 2030</title>
		<link>https://www.worldpharmatoday.com/press-releases/telangana-aims-to-emerge-as-indias-life-sciences-innovation-capital-with-25b-investment-target-by-2030/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Tue, 18 Aug 2026 12:16:50 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biopharma Businesses]]></category>
		<category><![CDATA[Biopharmaceutical Development]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/telangana-aims-to-emerge-as-indias-life-sciences-innovation-capital-with-25b-investment-target-by-2030/</guid>

					<description><![CDATA[<p>Strengthening Domestic API Depth and Reducing Import Reliance Key to Global Competitiveness Reaching $300B Valuation Demands Rapid Innovation, Biologics Scale, and Sustainable Quality Standards” True Advantage Beyond Cost: Innovation and Global Regulatory Excellence Must Drive India’s Next Pharma Phase” As India sets an ambitious roadmap to reach a USD 130 billion pharmaceutical market valuation by [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/telangana-aims-to-emerge-as-indias-life-sciences-innovation-capital-with-25b-investment-target-by-2030/">Telangana Aims to Emerge as India’s Life Sciences Innovation Capital with $25B Investment Target by 2030</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>CPHI &#038; PMEC Shenzhen 2026 Attracts Unprecedented International Interest as Demand for AI-Driven Innovation Grows</title>
		<link>https://www.worldpharmatoday.com/press-releases/cphi-pmec-shenzhen-2026-attracts-unprecedented-international-interest-as-demand-for-ai-driven-innovation-grows/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Mon, 17 Aug 2026 11:53:51 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biopharma Businesses]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/cphi-pmec-shenzhen-2026-attracts-unprecedented-international-interest-as-demand-for-ai-driven-innovation-grows/</guid>

					<description><![CDATA[<p>CPHI &#38; PMEC Shenzhen 2026 is set to welcome its most international audience to date, reflecting growing global interest in South China&#8217;s rapidly evolving pharmaceutical market and the technologies driving the next generation of healthcare innovation. Taking place from 16-18 September 2026 at the Shenzhen Convention &#38; Exhibition Center (SZCEC), China, this year&#8217;s event is expected [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/cphi-pmec-shenzhen-2026-attracts-unprecedented-international-interest-as-demand-for-ai-driven-innovation-grows/">CPHI & PMEC Shenzhen 2026 Attracts Unprecedented International Interest as Demand for AI-Driven Innovation Grows</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Genesis AEC Highlights PharmaWater Pro® Modeling Capability for Early Stage Pharmaceutical Water System Design</title>
		<link>https://www.worldpharmatoday.com/press-releases/genesis-aec-highlights-pharmawater-pro-modeling-capability-for-early-stage-pharmaceutical-water-system-design/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Fri, 14 Aug 2026 12:45:52 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/genesis-aec-highlights-pharmawater-pro-modeling-capability-for-early-stage-pharmaceutical-water-system-design/</guid>

					<description><![CDATA[<p>Platform helps manufacturers evaluate sustainability, utilities, and lifecycle costs before committing to major infrastructure Genesis AEC, a consulting engineering firm specializing in pharmaceutical water and utility systems, is highlighting its PharmaWater Pro® modeling capability as part of its consulting services for pharmaceutical manufacturers planning new facilities or evaluating upgrades to existing water purification infrastructure. Pharmaceutical [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/genesis-aec-highlights-pharmawater-pro-modeling-capability-for-early-stage-pharmaceutical-water-system-design/">Genesis AEC Highlights PharmaWater Pro® Modeling Capability for Early Stage Pharmaceutical Water System Design</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>CPHI Launches New Sustainability Summit as Pharma Faces Growing Pressure to Deliver Sustainability Goals</title>
		<link>https://www.worldpharmatoday.com/press-releases/cphi-launches-new-sustainability-summit-as-pharma-faces-growing-pressure-to-deliver-sustainability-goals/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Thu, 13 Aug 2026 06:49:27 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biopharma Businesses]]></category>
		<category><![CDATA[Biopharmaceutical Development]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/cphi-launches-new-sustainability-summit-as-pharma-faces-growing-pressure-to-deliver-sustainability-goals/</guid>

					<description><![CDATA[<p>CPHI has announced the launch of the CPHI Sustainability Summit, a new two-day event dedicated to advancing sustainability across the pharmaceutical value chain. Taking place at Fiera Milano, Italy, on 5-6 October 2026, alongside CPHI Milan, the summit will bring together more than 300 sustainability leaders, pharmaceutical executives and supply chain stakeholders to discuss practical action on one of [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/cphi-launches-new-sustainability-summit-as-pharma-faces-growing-pressure-to-deliver-sustainability-goals/">CPHI Launches New Sustainability Summit as Pharma Faces Growing Pressure to Deliver Sustainability Goals</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Container Closure Integrity by Design &#8211; From Clinical to Commercial Manufacturing</title>
		<link>https://www.worldpharmatoday.com/press-releases/container-closure-integrity-by-design-from-clinical-to-commercial-manufacturing/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Wed, 05 Aug 2026 09:24:29 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/container-closure-integrity-by-design-from-clinical-to-commercial-manufacturing/</guid>

					<description><![CDATA[<p>Learn how hidden process drift during capping and crimping can affect container closure integrity, and how earlier force visibility helps teams support CCI assurance before defects become rejects. Airing Live on August 20, 2026 11:00AM EST &#124; 5:00PM CEST Register Now From Clinical to Commercial Manufacturing Container closure integrity testing confirms whether a package meets [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/container-closure-integrity-by-design-from-clinical-to-commercial-manufacturing/">Container Closure Integrity by Design – From Clinical to Commercial Manufacturing</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
	</channel>
</rss>
